Importantly, the results showed that CRC patients with tumours with high SSRP1 expression levels had markedly shorter DFS and RFS than those with tumours with low SSRP1 expression (Figure S1A,B) (P = 0.0025 and P = 0.019, respectively). The gene discussed is SSRP1; the disease is neoplasm.